Latest Breaking News On - Igan rare disease group - Page 1 : comparemela.com

Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today

United kingdomLong island jewish medical centerNew yorkUnited statesJonathan barrattJoyce allaireRichard lafayetteMari purpuraStanford university department of medicineNephrology at stanford universityCommunications committeeStanford glomerular disease centerRenal research groupGlomerular disease advisory committeeAmerican society of nephrologyLotte new york palace hotel

Vera Therapeutics Hosting a Key Opinion Leader Webinar on

BRISBANE, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and.

United kingdomUnited statesJonathan barrattUniversity of leicesterInternational igan networkRenal research groupVera therapeutics incCollege of life sciencesAmerican society of nephrology kidney health initiativeIgan rare disease groupVera therapeuticsLife sciencesDisease groupUnited kingdom national registryRare kidney diseasesChief investigator

Vera Therapeutics to Host Key Opinion Webinar on Targeting the Source of IgA Nephropathy (IgAN) Featuring Jonathan Barratt, Ph D , FRCP

Vera Therapeutics to Host Key Opinion Webinar on Targeting the Source of IgA Nephropathy (IgAN) Featuring Jonathan Barratt, Ph D , FRCP
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaire lifesciJonathan barrattUniversity of leicesterInternational igan networkRenal research groupVera therapeutics incKathy vincentgreig communications incDrug administrationKidney health initiativeExchange commissionCollege of life sciencesAmerican society of nephrologyEuropean unionIgan rare disease groupWall street